101-20-2
Chemical Structure
Triclocarban
Synonym(s): 3,4,4′-Trichlorocarbanilide
- CAS No.: 101-20-2
- Formula:C13H9Cl3N2O
- Molecular Weight:315.58
IUPAC Name: 1-(4-chlorophenyl)-3-(3,4-dichlorophenyl)urea
InChIKey: ICUTUKXCWQYESQ-UHFFFAOYSA-N
SMILES: ClC1=CC=C(C=C1)NC(NC2=CC=C(C(Cl)=C2)Cl)=O
Biological Activity: Triclocarban (3,4,4′-Trichlorocarbanilide), a broad spectrum antibacterial compound, is widely used in a broad range of applications such as the production of soaps, skin creams, toothpastes and deodorants. Triclocarban is a potential endocrine-disrupting chemical with the capacity to modulate androgen and estrogen activities as well as other hormone-mediated biological processes[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Triclocarban | 98.93% | Triclocarban (3,4,4′-Trichlorocarbanilide), a broad spectrum antibacterial compound, is widely used in a broad range of applications such as the production of soaps, skin creams, toothpastes and deodorants. Triclocarban is a potential endocrine-disrupting chemical with the capacity to modulate androgen and estrogen activities as well as other hormone-mediated biological processes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Triclocarban (Standard) | 99.15% | Triclocarban (Standard) (3,4,4′-Trichlorocarbanilide (Standard)) is the analytical standard of Triclocarban (HY-B1805). This product is intended for research and analytical applications. Triclocarban, a broad spectrum antibacterial compound, is widely used in a broad range of applications such as the production of soaps, skin creams, toothpastes and deodorants. Triclocarban is a potential endocrine-disrupting chemical with the capacity to modulate androgen and estrogen activities as well as other hormone-mediated biological processes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Triclocarban-13C6 | Triclocarban-13C6 is the 13C labeled isotope of Triclocarban (HY-B1805). Triclocarban (3,4,4′-Trichlorocarbanilide), a broad spectrum antibacterial compound, is widely used in a broad range of applications such as the production of soaps, skin creams, toothpastes and deodorants. Triclocarban is a potential endocrine-disrupting chemical with the capacity to modulate androgen and estrogen activities as well as other hormone-mediated biological processes. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Triclocarban-d4 | 98.09% | Triclocarban-d4 is the deuterium labeled Triclocarban. Triclocarban (3,4,4′-Trichlorocarbanilide), a broad spectrum antibacterial compound, is widely used in a broad range of applications such as the production of soaps, skin creams, toothpastes and deodorants. Triclocarban is a potential endocrine-disrupting chemical with the capacity to modulate androgen and estrogen activities as well as other hormone-mediated biological processes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Triclocarban-13C13 | Triclocarban-13C13 (3,4,4'-Trichlorocarbanilide-13C13) is 13C labeled Triclocarban. Triclocarban (3,4,4′-Trichlorocarbanilide), a broad spectrum antibacterial compound, is widely used in a broad range of applications such as the production of soaps, skin creams, toothpastes and deodorants. Triclocarban is a potential endocrine-disrupting chemical with the capacity to modulate androgen and estrogen activities as well as other hormone-mediated biological processes. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Kanbara Y, et al. Nanomolar concentration of triclocarban increases the vulnerability of rat thymocytes to oxidative stress. J Toxicol Sci. 2013 Feb;38(1):49-55. [Content Brief]
- [2]. Huang H, et al. The in vitro estrogenic activities of triclosan and triclocarban. J Appl Toxicol. 2014 Sep;34(9):1060-7. [Content Brief]
- [3]. Kennedy RC, et al. Early life triclocarban exposure during lactation affects neonate rat survival. Reprod Sci. 2015 Jan;22(1):75-89. [Content Brief]